| Literature DB >> 30340830 |
Ya Wang1, Wenhan Ma1, Shuai Lu1, LianHua Yan1, Fen Hu1, ZhaoHui Wang2, Bo Cheng3.
Abstract
Cardiac fibrosis is an important cardiac remodeling event in the development of inflammation dilated cardiomyopathy (iDCM). We have previously observed that degradation enhancer of androgen receptor (ASC-J9®) could improve cardiac inflammation and fibrosis. Using Primary CFs, we demonstrated that ASC-J9® attenuates the expression of miR-125b, which subsequently inhibits the generation of collagen. In contrast, overexpressed AR in CFs induced collagen production, increases mir-125b.We also found that inhibition of miR-125b attenuates fibrosis which induced by the overexpression of AR. Our results indentify the functional role for AR as a regulator of cardiac fibrosis due to myocarditis and further show that AR exerts its effect by increasing microRNA-125b expression. Treatment with degradation enhancer of AR limits cardiac fibrosis in iDCM, thereby providing potentially a therapeutic approach for patients with iDCM.Entities:
Keywords: Androgen receptor; Cardiac fibrosis; Experimental autoimmune myocarditis; microRNA-125b
Mesh:
Substances:
Year: 2018 PMID: 30340830 DOI: 10.1016/j.bbrc.2018.09.092
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575